Start for free
Start for free
Vives Louvain Technology Fund logo

Vives Louvain Technology Fund

Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve

Description

Vives is an interregional seed and early stage technology multi-sector fund.

Investor Profile

Vives Louvain Technology Fund has made 25 investments, with 0 in the past 12 months and 4% as lead.

Stage Focus

  • Series A (36%)
  • Series B (36%)
  • Series Unknown (12%)
  • Seed (12%)
  • Series C (4%)

Country Focus

  • Belgium (76%)
  • France (12%)
  • United States (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Wellness
  • Agtech
  • Dietary Supplements
  • Nutraceutical
  • Therapeutics
  • Electronics
  • Medical
  • Agriculture
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Vives Louvain Technology Fund frequently co-invest with?

New Science Ventures
New Science Ventures
North America, Connecticut, United States, Greenwich
Co-Investments: 3
Gemma Frisius Fund
Gemma Frisius Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 3
AI
Agri Investment Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 3
VIB
VIB
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 4
Fund+
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 4
V-Bio Ventures
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 5
N
Nivelinvest
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 3
European Innovation Council
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3
S.R.I.W.
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 9
PMV
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3

Which angels does Vives Louvain Technology Fund often collaborate with?

OV
Olivier van der Rest
Europe, Belgium
Shared Deals: 1
PD
Pierre Drion
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1

What are some of recent deals done by Vives Louvain Technology Fund?

Sunrise

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

We are a virtual sleep clinic, using our own 3-gram sensor to diagnose sleep with gold standard quality.

Health CareHealth DiagnosticsHome Health CareLifestyleMedical DeviceWellness
Series AMar 9, 2023
Amount Raised: $17,996,293
Novadip Biosciences

Mont-saint-guibert, Brabant Wallon, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

BiotechnologyHealth CareMedicalTherapeutics
Series BNov 3, 2022
Amount Raised: $23,398,518
BOTALYS

Ghislenghien, Hainaut, Belgium

We seek wild precision for the Nutraceutical industry by developing pristine bioactive botanicals, using indoor farming.

AgTechBiotechnologyDietary SupplementsHealth CareNutraceuticalWellness
Series BOct 4, 2022
Amount Raised: $6,639,040

Spinovit is developing a method for the quantitative analysis of an oxygen-sensitive blood biomarker to measure endothelial dysfunction.

Health CareHealth DiagnosticsMedical Device
SeedJan 1, 2022
Sunrise

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

We are a virtual sleep clinic, using our own 3-gram sensor to diagnose sleep with gold standard quality.

Health CareHealth DiagnosticsHome Health CareLifestyleMedical DeviceWellness
SeedDec 15, 2021
Amount Raised: $7,338,604
Novadip Biosciences

Mont-saint-guibert, Brabant Wallon, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

BiotechnologyHealth CareMedicalTherapeutics
Series BOct 28, 2021
Amount Raised: $22,196,495
Aphea.Bio

Zwijnaarde, Oost-Vlaanderen, Belgium

Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.

AgricultureBiotechnologyChemical
Series BApr 14, 2021
Amount Raised: $21,572,387
Aphea.Bio

Zwijnaarde, Oost-Vlaanderen, Belgium

Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.

AgricultureBiotechnologyChemical
Series BApr 1, 2021
Amount Raised: $4,711,425
Syndesi Therapeutics

Louvain-la-neuve, Vlaams-Brabant, Belgium

Syndesi Therapeutics develops a drug candidate for the treatment of consecutive cognitive disorders of various neurological conditions.

BiotechnologyHealth CarePharmaceutical
Series ASep 28, 2020
Amount Raised: $7,007,103
ExeVir Bio

Zwijnaarde, Oost-Vlaanderen, Belgium

ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.

BiotechnologyHealth CareLife ScienceTherapeutics
Series AJul 28, 2020
Amount Raised: $49,218,885
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator